Physician Profile
Based in Little Rock, AR, James H. Abraham, M.D. is listed in the NPI registry under rheumatology. According to Medicare claims data, James cared for 3,112 Medicare patients across 58,706 services. The services billed most often include injection, vedolizumab, intravenous, 1 mg, injection, denosumab, 1 mg, and injection, infliximab-abda, biosimilar, (renflexis), 10 mg.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
License numbers are what the provider reported to NPPES when the NPI was issued or updated. NPPES does not verify licensure; confirm current standing with the state licensing board.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
10001 LILE DR
Little Rock, AR 72205
Within Rheumatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Autoimmune
Bone
Bone Health
Connective Tissue
Genetic & Connective Tissue
Inflammatory
Joints
Nerve & Tendon
Skin & Soft Tissue
Skin & Vascular
Soft Tissue
Spine & Back
Vascular
Most searched procedures
Consultation
Consultations
Diagnostics & Injections
Education & Support
Imaging
Injections
Lab & Diagnostics
Lab Work
Medication Management
Pain Relief
Regenerative Medicine
58,706 services · 3,112 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
861 | More than most peers in Rheumatology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
639 | More than most peers in Rheumatology |
| Injection of additional new drug or substance into vein | Treatment | 96375 |
561 | More than most peers in Rheumatology |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Treatment | 96365 |
304 | More often than most peers in Rheumatology |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
276 | More often than most peers in Rheumatology |
| Administration of chemotherapy into vein, each additional hour | Treatment | 96415 |
181 | More often than most peers in Rheumatology |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96401 |
143 | As often as other peers in Rheumatology |
| Injection, vedolizumab, intravenous, 1 mg | Drug given | J3380 |
16,500 | As often as other peers in Rheumatology |
| Injection, denosumab, 1 mg | Drug given | J0897 |
13,920 | More often than most peers in Rheumatology |
| Injection, ondansetron hydrochloride, per 1 mg | Drug given | J2405 |
4,018 |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
James H. Abraham is a rheumatologist in Little Rock, AR. That is the designation recorded for this NPI in the federal registry, where it is listed as “Rheumatology”.
NPI registry
James H. Abraham is listed at 10001 Lile Dr, Little Rock, AR 72205. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (501) 227-8000. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
James H. Abraham's National Provider Identifier is 1417985714. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
James H. Abraham has 20+ years experience. Registered with an NPI since 2006. National Provider Identifiers only began in 2005, so a provider who qualified earlier may have practiced for longer than this.
NPI registry
According to Medicare billing data, James H. Abraham performs procedures including insertion of needle into vein for collection of blood sample; provides treatments such as administration of chemotherapy into vein, 1 hour or less and injection of additional new drug or substance into vein, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by James H. Abraham. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.